Literature DB >> 29069435

Auditory Verbal Hallucinations in Schizophrenia From a Levels of Explanation Perspective.

Kenneth Hugdahl1,2,3,4, Iris E Sommer1,5.   

Abstract

In the present article, we present a "Levels of Explanation" (LoE) approach to auditory verbal hallucinations (AVHs) in schizophrenia. Mental phenomena can be understood at different levels of explanation, including cultural, clinical, cognitive, brain imaging, cellular, and molecular levels. Current research on AVHs is characterized by accumulation of data at all levels, but with little or no interaction of findings between levels. A second advantage with a Levels of Explanation approach is that it fosters interdisciplinarity and collaboration across traditional borders, facilitating a real breakthrough in future research. We exemplify a Levels of Explanation approach with data from 3 levels where findings at 1 level provide predictions for another level. More specifically, we show how functional neuroimaging data at the brain level correspond with behavioral data at the cognitive level, and how data at these 2 levels correspond with recent findings of changes in neurotransmitter function at the cellular level. We further discuss implications for new therapeutic interventions, and the article is ended by suggestion how future research could incorporate genetic influences on AVHs at the molecular level of explanation by providing examples for animal work.

Entities:  

Mesh:

Year:  2018        PMID: 29069435      PMCID: PMC5814913          DOI: 10.1093/schbul/sbx142

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  44 in total

Review 1.  Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.

Authors:  A Carlsson; N Waters; S Holm-Waters; J Tedroff; M Nilsson; M L Carlsson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome.

Authors:  B K Goodman; J Rutberg; W W Lin; A E Pulver; G H Thomas
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

3.  Auditory verbal hallucinations and cognitive functioning in healthy individuals.

Authors:  Kirstin Daalman; Martine van Zandvoort; Florian Bootsman; Marco Boks; René Kahn; Iris Sommer
Journal:  Schizophr Res       Date:  2011-08-12       Impact factor: 4.939

4.  A new verbal reports fMRI dichotic listening paradigm for studies of hemispheric asymmetry.

Authors:  Maurits van den Noort; Karsten Specht; Lars M Rimol; Lars Ersland; Kenneth Hugdahl
Journal:  Neuroimage       Date:  2007-12-14       Impact factor: 6.556

Review 5.  The treatment of hallucinations in schizophrenia spectrum disorders.

Authors:  Iris E C Sommer; Christina W Slotema; Zafiris J Daskalakis; Eske M Derks; Jan Dirk Blom; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2012-02-24       Impact factor: 9.306

6.  Competition for neuronal resources: how hallucinations make themselves heard.

Authors:  Daniela Hubl; Thomas Koenig; Werner K Strik; Lester Melie Garcia; Thomas Dierks
Journal:  Br J Psychiatry       Date:  2007-01       Impact factor: 9.319

7.  Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.

Authors:  Grégory Raux; Emilie Bumsel; Bernadette Hecketsweiler; Therese van Amelsvoort; Janneke Zinkstok; Sylvie Manouvrier-Hanu; Carole Fantini; Georges-Marie M Brévière; Gabriella Di Rosa; Giuseppina Pustorino; Annick Vogels; Ann Swillen; Solenn Legallic; Jacqueline Bou; Gaelle Opolczynski; Valérie Drouin-Garraud; Marie Lemarchand; Nicole Philip; Aude Gérard-Desplanches; Michèle Carlier; Anne Philippe; Marie Christine Nolen; Delphine Heron; Pierre Sarda; Didier Lacombe; Cyril Coizet; Yves Alembik; Valérie Layet; Alexandra Afenjar; Didier Hannequin; Caroline Demily; Michel Petit; Florence Thibaut; Thierry Frebourg; Dominique Campion
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

8.  Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study.

Authors:  Lahcen Ait Bentaleb; Mario Beauregard; Peter Liddle; Emmanuel Stip
Journal:  J Psychiatry Neurosci       Date:  2002-03       Impact factor: 6.186

9.  [Hallucinations attributed to djinns].

Authors:  Jan Dirk Blom; Hafize Eker; Hillal Basalan; Youssef Aouaj; Hans Wijbrand Hoek
Journal:  Ned Tijdschr Geneeskd       Date:  2010

10.  The role of the primary auditory cortex in the neural mechanism of auditory verbal hallucinations.

Authors:  Kristiina Kompus; Liv E Falkenberg; Josef J Bless; Erik Johnsen; Rune A Kroken; Bodil Kråkvik; Frank Larøi; Else-Marie Løberg; Einar Vedul-Kjelsås; René Westerhausen; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2013-04-24       Impact factor: 3.169

View more
  25 in total

Review 1.  [Cognitive control in the research domain criteria system: clinical implications for auditory verbal hallucinations].

Authors:  Katharina M Kubera; Dusan Hirjak; Nadine D Wolf; Robert C Wolf
Journal:  Nervenarzt       Date:  2021-08-03       Impact factor: 1.214

2.  The Reification of Diagnosis in Psychiatry.

Authors:  Drozdstoy Stoyanov
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

3.  Relating Glutamate, Conditioned, and Clinical Hallucinations via 1H-MR Spectroscopy.

Authors:  Pantelis Leptourgos; Sonia Bansal; Jenna Dutterer; Adam Culbreth; Albert Powers; Praveen Suthaharan; Joshua Kenney; Molly Erickson; James Waltz; S Andrea Wijtenburg; Frank Gaston; Laura M Rowland; James Gold; Philip Corlett
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

4.  Patients with first-episode untreated schizophrenia who experience concomitant visual disturbances and auditory hallucinations exhibit co-impairment of the brain and retinas-a pilot study.

Authors:  Chuanjun Zhuo; Bo Xiao; Feng Ji; Xiaodong Lin; Deguo Jiang; Hongjun Tian; Yong Xu; Wenqiang Wang; Ce Chen
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

5.  Exploration of the cortical pathophysiology underlying visual disturbances in schizophrenia comorbid with depressive disorder-An evidence from mouse model.

Authors:  Jian Liu; Lidan Zheng; Tao Fang; Ranli Li; Xiaoyan Ma; Yun Sun; Lina Wang; Hongjun Tian; Deguo Jiang; Chuanjun Zhuo
Journal:  Brain Behav       Date:  2021-03-17       Impact factor: 2.708

6.  Global functional connectivity density alterations in patients with bipolar disorder with auditory verbal hallucinations and modest short-term effects of transcranial direct current stimulation augmentation treatment-Baseline and follow-up study.

Authors:  Chuanjun Zhuo; Feng Ji; Xiaodong Lin; Hongjun Tian; Lina Wang; Yong Xu; Wenqiang Wang; Deguo Jiang
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

Review 7.  Auditory Hallucinations as Translational Psychiatry: Evidence from Magnetic Resonance Imaging.

Authors:  Kenneth Hugdahl
Journal:  Balkan Med J       Date:  2017-10-11       Impact factor: 2.021

8.  A unified model of shared brain structural alterations in patients with different mental disorders who experience own-thought auditory verbal hallucinations-A pilot study.

Authors:  Chuanjun Zhuo; Chunxiang Wang; Xueqin Song; Xuexin Xu; Gongying Li; Xiaodong Lin; Yong Xu; Hongjun Tian; Deguo Jiang; Wenqiang Wang; Chunhua Zhou
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

9.  Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow-up study.

Authors:  Chuanjun Zhuo; Bo Xiao; Ce Chen; Deguo Jiang; Gongying Li; Xiaoyan Ma; Ranli Li; Lina Wang; Yong Xu; Chunhua Zhou; Xiaodong Lin
Journal:  Brain Behav       Date:  2020-04-14       Impact factor: 2.708

10.  Imaging Violence in Schizophrenia: A Systematic Review and Critical Discussion of the MRI Literature.

Authors:  Maria Fjellvang; Linda Grøning; Unn K Haukvik
Journal:  Front Psychiatry       Date:  2018-07-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.